Experimental Lilly drug may help slow mental decline in people with mild Alzheimer's disease

BOSTON - Combined results from two studies of an experimental Alzheimer's drug suggest it might modestly slow mental decline, especially in patients with mild disease. Taken separately, the studies on the drug — Eli Lilly & Co....More